{"nct_id":"NCT01091428","title":"Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer","status":"COMPLETED","status_verified_date":"2018-05","start_date":"2010-04-16","start_date_type":"ACTUAL","primary_completion_date":"2014-08-12","primary_completion_date_type":"ACTUAL","completion_date":"2017-07-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}